blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1463758

EP1463758 - MAMMALIAN PROLACTIN VARIANTS [Right-click to bookmark this link]
Former [2004/41]MAMMAL PROLACTIN VARIANTS
[2009/09]
StatusNo opposition filed within time limit
Status updated on  08.01.2010
Database last updated on 30.10.2024
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR		published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
101, rue de Tolbiac
75013 Paris / FR
[2009/10]
Former [2004/41]For all designated states
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
101, rue de Tolbiac
75013 Paris / FR
Inventor(s)01 / GOFFIN, Vincent
2, impasse des Chèvrefeuilles
F-78910 ORGERUS / FR
02 / BERNICHTEIN, Sophie
61, rue des Ecoles
F-93300 AUBERVILLIERS / FR
03 / KELLY, Paul, A.
54, rue Notre Dame de Lorette
F-75009 PARIS / FR
 [2004/41]
Representative(s)Vialle-Presles, Marie José, et al
Cabinet ORES
36,rue de St Pétersbourg
75008 Paris / FR
[N/P]
Former [2004/41]Vialle-Presles, Marie José, et al
Cabinet ORES, 36,rue de St Pétersbourg
75008 Paris / FR
Application number, filing date03729258.808.01.2003
[2004/41]
WO2003EP00448
Priority number, dateEP2002029003008.01.2002         Original published format: EP 02290030
[2004/41]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03057729
Date:17.07.2003
Language:EN
[2003/29]
Type: A2 Application without search report 
No.:EP1463758
Date:06.10.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 17.07.2003 takes the place of the publication of the European patent application.
[2004/41]
Type: B1 Patent specification 
No.:EP1463758
Date:04.03.2009
Language:EN
[2009/10]
Search report(s)International search report - published on:EP16.10.2003
ClassificationIPC:C07K14/575
[2004/41]
CPC:
A61K38/2257 (EP,US); A61P15/00 (EP); A61P19/02 (EP);
A61P29/00 (EP); A61P35/00 (EP); A61P37/02 (EP);
A61P43/00 (EP); A61P7/00 (EP); C07K14/57554 (EP,US);
A01K2217/05 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2004/41]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
TitleGerman:VARIANTEN VON SÄUGERPROLACTIN[2004/41]
English:MAMMALIAN PROLACTIN VARIANTS[2009/09]
French:VARIANTES GENETIQUES DE PROLACTINE DE MAMMIFERE[2004/41]
Former [2004/41]MAMMAL PROLACTIN VARIANTS
Entry into regional phase19.07.2004National basic fee paid 
19.07.2004Designation fee(s) paid 
19.07.2004Examination fee paid 
Examination procedure01.08.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
02.08.2004Examination requested  [2004/41]
03.04.2007Despatch of a communication from the examining division (Time limit: M06)
11.10.2007Reply to a communication from the examining division
19.08.2008Communication of intention to grant the patent
18.12.2008Fee for grant paid
18.12.2008Fee for publishing/printing paid
Opposition(s)07.12.2009No opposition filed within time limit [2010/06]
Fees paidRenewal fee
24.01.2005Renewal fee patent year 03
20.01.2006Renewal fee patent year 04
25.01.2007Renewal fee patent year 05
16.01.2008Renewal fee patent year 06
19.12.2008Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT04.03.2009
BE04.03.2009
CY04.03.2009
CZ04.03.2009
DK04.03.2009
EE04.03.2009
FI04.03.2009
NL04.03.2009
SI04.03.2009
SK04.03.2009
TR04.03.2009
BG04.06.2009
SE04.06.2009
GR05.06.2009
PT19.08.2009
HU05.09.2009
[2012/47]
Former [2012/42]AT04.03.2009
BE04.03.2009
CY04.03.2009
CZ04.03.2009
DK04.03.2009
EE04.03.2009
FI04.03.2009
NL04.03.2009
SI04.03.2009
SK04.03.2009
BG04.06.2009
SE04.06.2009
GR05.06.2009
PT19.08.2009
HU05.09.2009
Former [2012/37]AT04.03.2009
BE04.03.2009
CY04.03.2009
CZ04.03.2009
DK04.03.2009
EE04.03.2009
FI04.03.2009
NL04.03.2009
SI04.03.2009
SK04.03.2009
BG04.06.2009
SE04.06.2009
GR05.06.2009
PT19.08.2009
Former [2010/48]AT04.03.2009
BE04.03.2009
CZ04.03.2009
DK04.03.2009
EE04.03.2009
FI04.03.2009
NL04.03.2009
SI04.03.2009
SK04.03.2009
BG04.06.2009
SE04.06.2009
GR05.06.2009
PT19.08.2009
Former [2010/08]AT04.03.2009
BE04.03.2009
CZ04.03.2009
DK04.03.2009
EE04.03.2009
FI04.03.2009
NL04.03.2009
SI04.03.2009
SK04.03.2009
BG04.06.2009
SE04.06.2009
PT19.08.2009
Former [2009/50]AT04.03.2009
BE04.03.2009
CZ04.03.2009
EE04.03.2009
FI04.03.2009
NL04.03.2009
SI04.03.2009
SK04.03.2009
SE04.06.2009
PT19.08.2009
Former [2009/49]AT04.03.2009
BE04.03.2009
CZ04.03.2009
EE04.03.2009
FI04.03.2009
NL04.03.2009
SI04.03.2009
SE04.06.2009
PT19.08.2009
Former [2009/43]AT04.03.2009
BE04.03.2009
FI04.03.2009
NL04.03.2009
SI04.03.2009
SE04.06.2009
Former [2009/39]AT04.03.2009
FI04.03.2009
NL04.03.2009
SI04.03.2009
SE04.06.2009
Former [2009/36]FI04.03.2009
NL04.03.2009
SI04.03.2009
Former [2009/34]NL04.03.2009
Cited inInternational search[YD]  - S. BERNICHTEIN ET AL., "N-Terminal Deletion in Human Prolactin Enhances Biological Activity and Reduces Formation of Covalent Multimers", ENDO 2000, ENDOCRINE SOCIETY 82ND ANNUAL MEETING, TORONTO, (200006), page 153, XP001070977 [YD] 1-12 * abstract 613; page 153 *
 [YD]  - V. GOFFIN ET AL., "Antagonistic Properties of Human Prolactin Analogs That Show Paradoxical Agonistic Activity in the Nb2 Bioassay", J. BIOL. CHEM., (19960712), vol. 271, no. 28, pages 16573 - 16579, XP002921797 [YD] 1-12 * Discussion *

DOI:   http://dx.doi.org/10.1074/jbc.271.24.14353
 [A]  - M. LLOVERA ET AL., "Involvement of prolactin in breast cancer: redefining the molecular targets", EXPERIMENTAL GERONTOLOGY, (2000), vol. 35, pages 41 - 51, XP002198974 [A] * page 48, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/S0531-5565(99)00078-9
 [A]  - A. TCHELET ET AL., "Selective Modification at the N-terminal Region of Human Growth Hormone That Shows Antagonistic Activity", MOLECULAR AND CELLULAR ENDOCRINOLOGY, (1997), vol. 130, pages 141 - 152, XP002198975 [A] * abstract *

DOI:   http://dx.doi.org/10.1016/S0303-7207(97)00084-1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.